Ex-Pharma Exec Fights SEC 'Shadow Trading' Win At 9th Circ.
An ex-Medivation Inc. executive urged the Ninth Circuit on Thursday to scrap a jury verdict finding him liable in the U.S. Securities and Exchange Commission's first-ever "shadow trading" case, arguing the...To view the full article, register now.
Already a subscriber? Click here to view full article